Tìm theo
Tesmilifene
Các tên gọi khác (3) :
  • Depmpe
  • DPPE
  • N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine
Thuốc điều trị ung thư
Thuốc Gốc
Small Molecule
CAS: 98774-23-3
CTHH: C19H25NO
PTK: 283.4079
Tesmilifene is a novel potentiator of chemotherapy which, when added to doxorubicin, achieved an unexpected and very large survival advantage over doxorubicin alone in a randomized trial in advanced breast cancer.
Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Công thức hóa học
C19H25NO
Phân tử khối
283.4079
Monoisotopic mass
283.193614427
InChI
InChI=1S/C19H25NO/c1-3-20(4-2)14-15-21-19-12-10-18(11-13-19)16-17-8-6-5-7-9-17/h5-13H,3-4,14-16H2,1-2H3
InChI Key
InChIKey=NFIXBCVWIPOYCD-UHFFFAOYSA-N
IUPAC Name
[2-(4-benzylphenoxy)ethyl]diethylamine
Traditional IUPAC Name
[2-(4-benzylphenoxy)ethyl]diethylamine
SMILES
CCN(CC)CCOC1=CC=C(CC2=CC=CC=C2)C=C1
Độ hòa tan
9.05e-03 g/l
logP
4.64
logS
-4.5
pKa (Strongest Basic)
9.33
PSA
12.47 Å2
Refractivity
89.77 m3·mol-1
Polarizability
33.95 Å3
Rotatable Bond Count
8
H Bond Acceptor Count
2
H Bond Donor Count
0
Physiological Charge
1
Number of Rings
2
Bioavailability
1
Rule of Five
true
Ghose Filter
true
Cơ Chế Tác Dụng : Tesmilifene is a novel potentiator of chemotherapy which, when added to doxorubicin, achieved an unexpected and very large survival advantage over doxorubicin alone in a randomized trial in advanced breast cancer. Although the exact mechanism of action is not known, one study (PMID: 16413681) proposes that tesmilifene may be an activating p-gp substrate, which enables the p-gp pump to extrude typical p-gp substrates (such as anthracyclines or taxanes) more efficiently. This process consumes ATP, since the p-gp is absolutely, and highly dependent on ATP hydrolysis. The mechanism of cell death is likely to result not from the presence of chemotherapy inside the cell (in fact the chemotherapy is extruded) but, directly or indirectly, from the enhanced consumption of ATP. The ATP may be consumed below a threshold necessary for survival, or, (more likely) the enhanced ATP production required to maintain ATP levels may result in the generation of reactive oxygen species (ROS) to an extent that overwhelms the cell’s ability to inactivate them. The result would be additional cell death, but only in the mdr+ population. The doxorubicin would continue to act on the drug sensitive remainder of the cell population, but without the help of tesmilifene.
Dược Động Học :

▧ Metabolism :
Hepatic
Chỉ Định : Intended for the treatment of various forms of cancer.
Tài Liệu Tham Khảo Thêm
drugbank
http://www.drugbank.ca/drugs/DB04905
PubChem Compound
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=108092
PubChem Substance
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=10234594
ChemSpider
http://www.chemspider.com/Chemical-Structure.97190.html
BindingDB
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50085260
... loading
... loading